PGY1 @StanfordOHNS | @CleClinicLCM '22 | @JohnsHopkins '17 | Views my own
Joined June 2020
- Tweets19
- Following210
- Followers160
- Likes244
Thrilled to have matched @StanfordOHNS for residency! Huge thank you to family, friends, and mentors @CleClinicLCM! #Otomatch #Match2022
Maxwell Lee retweeted
AddThis | Home authors.elsevier.com/c/1dk13… This is wonderful work by Max Lee, Zi Ouyang, Danielle LaHurd, @PhDpingxia, along with @DrEHBalagamwala, @DrJohnSuh, @AnthonyMagnelli, @SBalikPhD and @DrLilyAngelov. I love the collaboration with physics.
Maxwell Lee retweeted
Great to see this #ASTRO19 abstract in full pub!
Recall: 24/1 may be assoc w vertebral compression fracture (VCF) rates of ~40%.
📌For 16-18 Gy, should we limit Dmax to 24 Gy (or consider 24/2)? 🤔
📌 MTT VCF ~1y (2y in Rose, 4mo in Sahgal).
#radonc pubmed.ncbi.nlm.nih.gov/3430…
Maxwell Lee retweeted
Read the newly published preclinical evaluation of #Precigen's PRGN-2012, a first-in-class investigational off-the-shelf AdenoVerse immunotherapy targeting infectious disease. View publication: bit.ly/3cR5Yjb $PGEN #Vaccine #InfectiousDisease
Maxwell Lee retweeted
Excited to share our latest work. We present NanoSeq, a new duplex sequencing method with <5 errors per billion sites in single DNA molecules. A leap in our ability to study mutation in any tissue. 1/ nature.com/articles/s41586-0…
Thrilled to finally share our work! We present PD-L1-targeting CAR NK cells as an "off the shelf" therapy that overcomes tumor heterogeneity when combined with T-cell immunotherapy in pre-clinical models.
Phase I/II clinical trials are already underway 📈📈📈
New #JITC article: Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells @MaxwellYLee ow.ly/cQiL50E6BRK
Maxwell Lee retweeted
In a phase 1 trial of patients with #HPV-associated metastatic epithelial cancers, HPV-16 E7-specific #Tcells elicited objective clinical responses in 6 of 12 treated patients #cervicalcancer #HNSCC #NMedClinical @NCIResearchCtr @nciccr_gmb @CSHinrichsMD go.nature.com/3tDKZHf
Maxwell Lee retweeted
Great paper from Zemin Zhang lab in @CellCellPress presenting a single cell atlas of tumor infiltrating #myeloid cells across cancers doi.org/10.1016/j.cell.2021.…
One key point: dendritic cell states are conserved across indications, which confirms our findings doi.org/10.1084/jem.20200264
Maxwell Lee retweeted
A paper published in Nature reports a single-cell multimodal imaging approach where genome organization, nuclear bodies, chromatin modifications and gene expression are determined in the same cell. go.nature.com/3owGB9e
Maxwell Lee retweeted
New #JITC article: Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies @gulleyj1 ow.ly/zXGj50COz3R
Happy to share our new article on antigen processing and presentation in cancer immunotherapy - a super exciting topic with lots of potential if taken advantage of! @NIDCD @jitcancer
Check out our @NIDCD recent article outlining the reasons why head and neck cancers may not respond to current immunotherapies. Looking forward to future research that addresses these challenges!
Maxwell Lee retweeted
NIDCD & @theNCI scientists have characterized immune cells that kill head & neck cancer cells in mice & reduce cells that allow tumors to escape immune response. bit.ly/38CFs9y #NIDCDresearch #hncsm @NIH @eLife